PAR · SAN.PA
Sanofi
€76.15+€0.64 (+0.85%)
Sanofi’s quoted price sits in the lower half of its reported 52-week range, 16.13% below the high.
Loading market information…
PAR · ALTAO.PA · EUR
Stock price, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Aton’s quoted price sits in the lower half of its reported 52-week range, 66.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aton’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in France, Aton operates as a bioscience enterprise, with its headquarters located in Strasbourg. Established in 1998, the company's extensive operations encompass pharmaceutical research and development, the provision of preclinical and clinical services, and the creation of monoclonal antibodies. Additionally, Aton manufactures laboratory equipment, designs and produces various medical devices—including specialized surgical instruments powered by Stemcis technology—and supplies human tissues.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€76.15+€0.64 (+0.85%)
Sanofi’s quoted price sits in the lower half of its reported 52-week range, 16.13% below the high.
€0.08€0.00 (0.0%)
TheraVet S.A.’s quoted price sits in the lower half of its reported 52-week range, 92.58% below the high.
€0.07€0.00 (0.0%)
Quantum Genomics S.A.’s quoted price sits in the lower half of its reported 52-week range, 53.48% below the high.
€0.28€0.00 (0.0%)
Lysogene S.A.’s quoted price sits in the lower half of its reported 52-week range, 65.87% below the high.
€0.25€0.00 (0.0%)
Acticor Biotech SAS’s quoted price sits in the lower half of its reported 52-week range, 95.28% below the high.
€0.35€0.00 (0.0%)
Medesis Pharma S.A.’s quoted price sits in the lower half of its reported 52-week range, 82.5% below the high.
€0.03€0.00 (0.0%)
Deinove S.A.’s quoted price sits in the lower half of its reported 52-week range, 93.92% below the high.
€0.10€0.00 (0.0%)
PHAXIAM Therapeutics S.A.’s quoted price sits in the lower half of its reported 52-week range, 95.31% below the high.
